Suppr超能文献

端粒和端粒酶在正常和肿瘤干细胞中的作用。

Telomeres and telomerase in normal and cancer stem cells.

机构信息

UT Southwestern Medical Center, Department of Cell Biology, Dallas, TX 75390, USA.

出版信息

FEBS Lett. 2010 Sep 10;584(17):3819-25. doi: 10.1016/j.febslet.2010.05.026. Epub 2010 May 21.

Abstract

Differences between normal adult tissue stem cells and cancer stem/initiating cells remain poorly defined. For example, it is controversial if cancer stem cells can become fully quiescent, require a stem cell niche, are better at repairing DNA damage than the bulk of the cancer cells, and if and how they regulate symmetric versus asymmetric cell divisions. This minireview will not only provide our personal views to address some of these outstanding questions, but also present evidence that an understanding of telomere dynamics and telomerase activity in normal and cancer stem cells may provide additional insights into how tumors are initiated, and how they should be monitored and treated.

摘要

正常成人组织干细胞和癌症干细胞/起始细胞之间的差异仍未得到很好的定义。例如,癌症干细胞是否可以完全静止、是否需要干细胞巢、是否比癌细胞更擅长修复 DNA 损伤,以及它们是否以及如何调节对称与非对称细胞分裂,这些问题仍存在争议。这篇简要综述不仅将提供我们个人的观点来解决其中的一些悬而未决的问题,还将提供证据表明,对正常和癌症干细胞中端粒动力学和端粒酶活性的理解可能为肿瘤的发生以及如何监测和治疗肿瘤提供更多的见解。

相似文献

1
Telomeres and telomerase in normal and cancer stem cells.
FEBS Lett. 2010 Sep 10;584(17):3819-25. doi: 10.1016/j.febslet.2010.05.026. Epub 2010 May 21.
2
Telomere and telomerase in stem cells: relevance in ageing and disease.
Front Biosci (Schol Ed). 2012 Jan 1;4(1):16-30. doi: 10.2741/248.
3
Extension of life-span by introduction of telomerase into normal human cells.
Science. 1998 Jan 16;279(5349):349-52. doi: 10.1126/science.279.5349.349.
4
The role of telomeres and telomerase in stem cell aging.
FEBS Lett. 2010 Sep 10;584(17):3826-30. doi: 10.1016/j.febslet.2010.07.042. Epub 2010 Aug 3.
5
Changes in telomerase activity and telomere length during human T lymphocyte senescence.
Exp Cell Res. 1997 Mar 15;231(2):346-53. doi: 10.1006/excr.1997.3475.
6
Telomeres and telomerase in stem cells during aging and disease.
Genome Dyn. 2006;1:84-103. doi: 10.1159/000092502.
7
Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
Methods Mol Biol. 2019;2045:217-224. doi: 10.1007/7651_2018_120.
9
Role of telomeres and telomerase in cancer.
Semin Cancer Biol. 2011 Dec;21(6):349-53. doi: 10.1016/j.semcancer.2011.10.001. Epub 2011 Oct 17.
10
CHK2-independent induction of telomere dysfunction checkpoints in stem and progenitor cells.
EMBO Rep. 2010 Aug;11(8):619-25. doi: 10.1038/embor.2010.83. Epub 2010 Jun 25.

引用本文的文献

1
The role of telomere and telomerase in cancer and novel therapeutic target: narrative review.
Front Oncol. 2025 Feb 14;15:1542930. doi: 10.3389/fonc.2025.1542930. eCollection 2025.
3
Downregulation of Aging-Associated Gene SUCLG1 Marks the Aggressiveness of Liver Disease.
Cancers (Basel). 2025 Jan 21;17(3):339. doi: 10.3390/cancers17030339.
4
models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade.
Front Cell Dev Biol. 2025 Jan 3;12:1463807. doi: 10.3389/fcell.2024.1463807. eCollection 2024.
5
Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle.
Adv Exp Med Biol. 2024;1460:821-850. doi: 10.1007/978-3-031-63657-8_27.
6
Heterozygous variant as a novel genetic cause of telomere biology disorders.
Genes Dev. 2024 Sep 19;38(15-16):755-771. doi: 10.1101/gad.352032.124.
7
Strategies for the Isolation and Identification of Gastric Cancer Stem Cells.
Stem Cells Int. 2024 Jun 6;2024:5553852. doi: 10.1155/2024/5553852. eCollection 2024.
8
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.
Cancer Gene Ther. 2024 Sep;31(9):1292-1305. doi: 10.1038/s41417-024-00768-6. Epub 2024 Apr 9.
9
No correlative evidence of costs of infection or immunity on leucocyte telomere length in a wild population of Soay sheep.
Proc Biol Sci. 2024 Apr 10;291(2020):20232946. doi: 10.1098/rspb.2023.2946. Epub 2024 Apr 3.
10
Illuminating Shared Genetic Associations Between Oesophageal Carcinoma and Pulmonary Carcinoma Risk.
J Cancer. 2024 Mar 4;15(8):2412-2423. doi: 10.7150/jca.92899. eCollection 2024.

本文引用的文献

2
Regulating the leukaemia stem cell.
Best Pract Res Clin Haematol. 2009 Dec;22(4):483-7. doi: 10.1016/j.beha.2009.08.005.
3
The effects of telomerase inhibition on prostate tumor-initiating cells.
Int J Cancer. 2010 Jul 15;127(2):321-31. doi: 10.1002/ijc.25043.
4
Efficient tumour formation by single human melanoma cells.
Nature. 2008 Dec 4;456(7222):593-8. doi: 10.1038/nature07567.
5
Cancer stem cells in multiple myeloma.
Cancer Lett. 2009 May 8;277(1):1-7. doi: 10.1016/j.canlet.2008.08.005. Epub 2008 Sep 21.
6
PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Cancer Res. 2008 Mar 15;68(6):1820-5. doi: 10.1158/0008-5472.CAN-07-5878.
7
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Br J Cancer. 2008 Feb 26;98(4):756-65. doi: 10.1038/sj.bjc.6604242. Epub 2008 Feb 12.
8
Cancer stem cells: at the headwaters of tumor development.
Annu Rev Pathol. 2007;2:175-89. doi: 10.1146/annurev.pathol.2.010506.091847.
9
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
Int J Cancer. 2008 Feb 15;122(4):761-8. doi: 10.1002/ijc.23130.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验